Portage Biotech (Portage Biotech) Short-Term Capital Lease Obligation : $0.05 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Portage Biotech Short-Term Capital Lease Obligation?

Portage Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.05 Mil.

Portage Biotech's quarterly Short-Term Capital Lease Obligation increased from Jun. 2023 ($0.05 Mil) to Sep. 2023 ($0.05 Mil) and increased from Sep. 2023 ($0.05 Mil) to Dec. 2023 ($0.05 Mil).

Portage Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Portage Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Short-Term Capital Lease Obligation Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	0.05	0.05	0.05

Portage Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Portage Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.